VIA
DGX icon

Vantage Investment Advisors’s Quest Diagnostics DGX Stock Holding History

Vantage Investment Advisors’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		$7K Hold
67
– – ﹤0.01% 591
2018
Q2 		$7K Hold
67
– – ﹤0.01% 593
2018
Q1 		$7K Hold
67
– – ﹤0.01% 615
2017
Q4 		$7K Buy
67
+3
+5% +$284 ﹤0.01% 631
2017
Q3 		$6K Buy
+64
New +$6.79K ﹤0.01% 634
2016
Q2 		– Sell
-19
Closed -$1K – 853
2016
Q1 		$1K Buy
+19
New +$1.27K ﹤0.01% 752
2015
Q2 		– Sell
-30
Closed -$2K – 772
2015
Q1 		$2K Buy
+30
New +$2.15K ﹤0.01% 762

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
FMI
Fiduciary Management Inc Milwaukee, Wisconsin $7.03B AUM 11.68% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
MWNA
Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Bessemer Group
Bessemer Group Woodbridge, New Jersey $72.7B AUM 39.36% 1-Year Est. Return

Vantage Investment Advisors's DGX Position: Q3 2018 in Review

Vantage Investment Advisors held its Quest Diagnostics (DGX) position steady in Q3 2018 at 67 shares worth $7K. The position accounts for ﹤0.01% of the portfolio, ranked #591.

Vantage Investment Advisors first reported a position in DGX in Q1 2015 and has held it in 7 quarters since. 674 funds tracked by Wall St. Rank hold DGX as of Q3 2018.

  • Vantage Investment Advisors held 67 shares of Quest Diagnostics worth $7K as of Q3 2018.
  • Vantage Investment Advisors left its Quest Diagnostics share count unchanged in Q3 2018.
  • Quest Diagnostics made up ﹤0.01% of Vantage Investment Advisors's portfolio in Q3 2018, its #591 holding.
  • Vantage Investment Advisors first reported a position in Quest Diagnostics in Q1 2015 and has held it in 7 quarters since.
  • 674 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2018.

Based on Vantage Investment Advisors's 13F filing for Q3 2018, filed 9 Nov 2018.